• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Abbott, WeightWatchers unveil connected diabetes app

September 19, 2023 By Sean Whooley

Abbott Freestyle Libre 2
The FreeStyle Libre 2, part of the integrated offering with WeightWatchers. (Image courtesy of Abbott)

Abbott (NYSE:ABT) and WeightWatchers today announced the availability of a connected app for people living with diabetes.

In August 2022, the companies announced a collaboration to integrate continuous glucose monitoring (CGM) with the WW diabetes-tailored plan. The integrated offering provides a mobile experience with information and insights needed for those with diabetes. It helps to make healthy adjustments to their diet, improve their glucose levels and gain more control of their health.

The app helps people with diabetes understand how food and activity impact their glucose levels. WeightWatchers members who follow the tailored plan can now access their glucose data from the Abbott FreeStyle Libre 2 CGM. This all works within their WW app while under guidance from the WW diabetes-tailored plan.

Abbott and WeightWatchers teamed up because of the importance of maintaining healthy weight with glucose control. This especially rings true for people with type 2 diabetes aiming to improve their wellbeing and prevent diabetes progression.

“Clinical data shows that healthy weight loss leads to a reduction of average glucose which is important for people living with diabetes,” said Dr. Mahmood Kazemi, chief medical officer for Abbott’s diabetes care business. “Abbott and WeightWatchers both have a long history of helping people live healthier lives. Through our partnership, members of the WW Diabetes-Tailored Plan can see within one app how food and activity impact their glucose levels with data backed by our FreeStyle Libre 2 system, so they can make healthy lifestyle choices. “

More about Abbott and WeightWatchers’ collaboration

WeightWatchers had a team of nutrition and behavioral science experts designed its tailored plan. It aims to help people with type 2 diabetes form helpful habits and meet their health goals.

The plan has demonstrated success in helping people with diabetes lose weight and lower their HbA1c, the company said.

From now until Dec. 31, 2023, new WeightWatchers members can receive a free month fo the tailored plan. They can then connect the WW app with the FreeStyle Libre 2 system. Any new FreeStyle Libre 2 users may be eligible to receive a voucher for a free trial of the system when they sign up for the MyFreeStyle Libre program.

“WeightWatchers is the #1 doctor-recommended weight-management program2, and our WW diabetes-tailored plan has been proven to reduce members hemoglobin A1c by 0.76 and decrease diabetes distress by 9.8 percent8,” said Gary Foster, chief scientific officer for WeightWatchers. “Together, our two trusted brands are helping people living with Type 2 diabetes better understand and manage their chronic condition and gain control of their health while still enjoying the foods they love.”

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured Tagged With: abbott, WeightWatchers

IN CASE YOU MISSED IT

  • Insulet’s Omnipod Discover data platform begins full US rollout
  • BD’s IV catheters plant in Utah marks 70 years
  • Novo taps Nanexa for long-acting obesity injectables with €1.17B pact
  • Abbott partners with Berry Street to add nutrition coaching to Lingo
  • Dexcom CFO to expand into COO role

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS